Spectrum Dynamics nets first Nevada order for D-SPECT

Southwest Medical Associates in Las Vegas has installed a D-SPECT nuclear imaging camera from Spectrum Dynamics in its cardiology department.

The D-SPECT camera, developed by Spectrum Dynamics, provides improved sensitivity by collecting photons using larger collection angles, a novel design of scanning solid-state detectors and image reconstruction techniques. This technology is capable of acquiring patient data up to 10-times faster than a conventional sodium iodide-based system and provides clinicians with cardiac flow data.

“The D-SPECT camera’s nuclear imaging technology produces sharper diagnostic images to detect blockages and other significant problems in coronary arteries for patients for whom this test is indicated,” said Joseph Kaufman, MD, president of Southwest Medical Associates and a practicing cardiologist. “A quick, sharp image helps with early disease detection for appropriate individuals and is a much less stressful experience for patients.”

Southwest Medical Associates’ nuclear cardiology department is accredited by the Intersocietal Commission for the Accreditation of Nuclear Medicine Laboratories (ICANL). The D-SPECT camera at Southwest Medical Associates is only the 17th currently in use in the U.S. The first cameras were installed and tested at Cedar-Sinai Medical Center in Los Angeles, Baptist Cardiac Vascular Institute in Miami, and Vanderbilt University Medical Center in Nashville.

Southwest Medical Associates is a wholly-owned subsidiary of UnitedHealthcare and operates 14 medical clinics throughout Las Vegas, including several urgent care centers and an outpatient surgery center. The clinics are staffed by approximately 250 physicians and physician extenders.







Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.